Investor Relations
|
Media Center
|
Careers
|
Contact
Home
Our Company
Our Experience
Our Divisions
Media Center
Media Center
Media Center
Media Center
Press Releases
Download Library
Media Center
Press Releases
Download Library
Media Center
Home
»
Media Center
»
Press Releases
Normal
Press Releases
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
May 20, 2013
Impax Board of Directors Establishes Compliance Committee
May 20, 2013
Impax Laboratories to Present at the UBS Global Healthcare Conference
May 17, 2013
Impax Laboratories Launches Authorized Generic of Zomig (zolmitriptan) Tablets and Orally Disintegrating Tablets in the U.S.
May 10, 2013
Impax Laboratories to Present at the Bank of America Merrill Lynch 2013 Health Care Conference
May 1, 2013
Impax Laboratories Reports First Quarter 2013 Results
April 29, 2013
Impax Pharmaceuticals and GlaxoSmithKline Terminate Their Collaboration on IPX066 (RYTARYTM)
April 3, 2013
Impax Laboratories Schedules Conference Call and Webcast for First Quarter 2013 Financial Results
March 19, 2013
Impax Pharmaceuticals Announces Presentation of RYTARYTM (IPX066) (Carbidopa and Levodopa) Extended-Release Capsules Phase III and Open-Label Extension Data at the American Academy of Neurology 2013 Annual Meeting
March 15, 2013
RYTARYTM (IPX066) (Carbidopa and Levodopa) Extended-Release Capsules Phase III and Open-Label Extension Data to be Presented at the American Academy of Neurology Conference
March 4, 2013
Impax Provides an Update on FDA Inspection of Hayward Facility
March 1, 2013
Impax Laboratories to Present at the Cowen & Company 33rd Annual Health Care Conference
February 25, 2013
Impax Laboratories Reports Fourth Quarter and Full Year 2012 Results
February 8, 2013
Impax and Shire Settle Litigation Concerning Supply of Authorized Generic Adderall XR®
January 21, 2013
FDA Issues Complete Response Letter for RYTARY™ (Carbidopa and Levodopa) Extended-Release Capsules (IPX066) New Drug Application
January 17, 2013
Impax Laboratories Schedules Conference Call and Webcast for Fourth Quarter and Full Year 2012 Financial Results
January 4, 2013
Impax Laboratories Launches Oxymorphone Hydrochloride Extended-Release Tablets
January 2, 2013
Impax Laboratories to Present at the 31st Annual J.P. Morgan Healthcare Conference
Related Links
Products and Pipeline
Leadership
Contact
Investor Toolkit
Email Page
RSS Feeds
E-mail Alerts
Financial Tear Sheet
Copyright © 2011 Impax Laboratories, Inc. All rights reserved.
Sitemap
|
Legal and Copyright Disclaimer
Name
*
E-mail
*
Comments
Powered By Q4 Web Systems
3.8.1.5343